Deckers loses $47.3 million in fiscal first quarter
By Staff Report / Thursday, July 30th, 2015 / Latest news, Top Stories, Tri-County Public Companies / Comments Off on Deckers loses $47.3 million in fiscal first quarter
Goleta-based Deckers on July 30 reported a loss of $47.3 million in its fiscal first quarter and a loss of $1.43 on a per-share basis. Despite the per-share loss, the results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.51 per share. Deckers Read More →
Read More →Amgen second-quarter profit beats analysts’ estimates
By Staff Report / Thursday, July 30th, 2015 / Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen second-quarter profit beats analysts’ estimates
Thousand Oaks-based Amgen Inc. posted second-quarter profit that topped analysts’ estimates, driven by higher sales and lower operating expenses. The biotech also raised its revenue and earnings forecast for the year. Profit excluding one-time items rose to $2.57 a share, while analysts had predicted $2.43 on average. Revenue increased 3.7 percent to $5.37 billion, the Read More →
Read More →Venoco asks Goleta for permission to move two truckloads of oil per day
By Staff Report / Tuesday, July 28th, 2015 / Energy, Latest news, Top Stories / Comments Off on Venoco asks Goleta for permission to move two truckloads of oil per day
Venoco has asked the city of Goleta for emergency authority to move two truckloads per day of oil from its Ellwood facility to Santa Maria for the next 17 days. Venoco said it was making the request so that lines and other facilities could be cleared in order to complete mandatory inspections. Venoco said it Read More →
Read More →Bauerlein to keynote 2015 Spirit of Small Business awards
By Staff Report / Monday, July 27th, 2015 / Latest news, Top Stories / Comments Off on Bauerlein to keynote 2015 Spirit of Small Business awards
The Pacific Coast Business Times is pleased to announce our 2015 class of Spirit of Small Business award winners. The annual special section, now in its 13th year, celebrates small-business ownership and entrepreneurship in the Tri-Counties. The report published with the July 24 print edition of the Business Times. The honorees will be celebrated Read More →
Read More →UCSB named West Coast hub for Photonics Institute
By Staff Report / Monday, July 27th, 2015 / Latest news, South Coast, Technology, Top Stories / Comments Off on UCSB named West Coast hub for Photonics Institute
UC Santa Barbara’s Institute for Energy Efficiency will play a lead role in a $110 million federal program to develop new electronic products using the next generation of chip technology. UCSB will become the west coast hub for the newly formed American Institute for Manufacturing of Photonics (AIM), teaming with lead institution State University of Read More →
Read More →FDA approves Amgen’s Kyprolis
By Staff Report / Friday, July 24th, 2015 / Central Coast Health Watch, East Ventura County, Latest news, Top Stories, Tri-County Public Companies / Comments Off on FDA approves Amgen’s Kyprolis
The Food and Drug Administration approved Amgen’s Kyprolis for second-line treatments of multiple-myeloma on Friday. Thousand Oaks-based Amgen’s new treatment for multiple-myeloma could pay off big for the company now that the treatment can be accessed by more patients in the second line of treatments. Kyprolis was approved for third-line treatments in 2012. The FDA’s Read More →
Read More →Amgen submits data on cancer drug Kyprolis to FDA
By Staff Report / Thursday, July 23rd, 2015 / Central Coast Health Watch, Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen submits data on cancer drug Kyprolis to FDA
Thousand Oaks-based Amgen announced Thursday that it submitted data comparing its new multiple-myeloma drug against a rival to the Food and Drug Administration. Kyprolis is Amgen’s new treatment for multiple-myeloma, which is a form of blood cancer that forms in plasma cells and typically grows in bone marrow. The drug was approved for third-line treatments Read More →
Read More →Popular articles
- None Found
Sponsored content:
SHIPS SLOW TO PROTECT WHALES, BLUE SKIES
-
Sign up for email news
Get the Business Times in your inbox. Sign up for breaking news alerts, our weekly briefing, and more.Sign upFor Email Marketing you can trust.2015-2016 Giving Guide
Check out our 2015 Giving Guide special issue
